OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(4)
Publication Date
Release Date
2011
(3)
2009
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.
Not available
S-EPMC2638696
|
biostudies-literature
Cite
A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability.
Not available
S-EPMC3152869
|
biostudies-literature
Cite
Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale.
Not available
S-EPMC3150329
|
biostudies-literature
Cite
The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United Kingdom.
Not available
S-EPMC3169589
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets